SCRN1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.063600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.828000E-01
Normal-vs-Stage2
5.267400E-01
Normal-vs-Stage3
5.734000E-02
Normal-vs-Stage4
7.730800E-01
Stage1-vs-Stage2
3.610800E-01
Stage1-vs-Stage3
1.798780E-01
Stage1-vs-Stage4
7.881200E-01
Stage2-vs-Stage3
1.280160E-01
Stage2-vs-Stage4
7.743800E-01
Stage3-vs-Stage4
1.962050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.076800E-01
Normal-vs-AfricanAmerican
8.818000E-01
Normal-vs-Asian
4.268800E-01
Caucasian-vs-AfricanAmerican
6.171600E-01
Caucasian-vs-Asian
4.370000E-01
AfricanAmerican-vs-Asian
2.421000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.366200E-01
Normal-vs-Female
7.772000E-01
Male-vs-Female
9.687800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.558600E-01
Normal-vs-Age(41-60Yrs)
8.398000E-01
Normal-vs-Age(61-80Yrs)
6.950000E-01
Normal-vs-Age(81-100Yrs)
2.131200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.170600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.222200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.872300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.726200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.939900E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.151600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.500010E-01
Normal-vs-Daily Drinker
4.547600E-01
Normal-vs-Weekly Drinker
2.254800E-01
Normal-vs-Occasional Drinker
6.210000E-01
Normal-vs-Social Drinker
9.402400E-01
Non Drinker-vs-Daily Drinker
1.769770E-01
Non Drinker-vs-Weekly Drinker
5.197000E-01
Non Drinker-vs-Occasional Drinker
1.306210E-02
Non Drinker-vs-Social Drinker
8.206100E-02
Daily Drinker-vs-Weekly Drinker
5.682400E-01
Daily Drinker-vs-Occasional Drinker
5.949500E-02
Daily Drinker-vs-Social Drinker
3.048800E-01
Weekly Drinker-vs-Occasional Drinker
3.066500E-02
Weekly Drinker-vs-Social Drinker
1.748370E-01
Occasional Drinker-vs-Social Drinker
4.254400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.248400E-01
Normal-vs-Grade 2
3.913600E-01
Normal-vs-Grade 3
2.260000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.860000E-02
Grade 1-vs-Grade 3
1.948560E-01
Grade 1-vs-Grade 4
4.248400E-01
Grade 2-vs-Grade 3
8.536300E-02
Grade 2-vs-Grade 4
3.913600E-01
Grade 3-vs-Grade 4
2.260000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.449400E-01
Normal-vs-NonDiabetic
8.833600E-01
Diabetic-vs-NonDiabetic
1.748360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.043600E-01
Normal-vs-NoPancreatitis
8.119200E-01
Pancreatitis-vs-NoPancreatitis
6.837600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.825400E-01
Normal-vs-N1
5.230800E-01
N0-vs-N1
1.979180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.420200E-01
Normal-vs-TP53-NonMutant
8.535600E-01
TP53-Mutant-vs-TP53-NonMutant
3.449200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
